Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune system modulation via inhibition of B-cell proliferation (B-cell proliferation inhibition)
- Target
- B-cell proliferation inhibition
- Molecular classification
- Immunomodulatory Agent
01
Overview
Strategies and molecular mechanisms that suppress the expansion and activity of B lymphocytes. This approach is central in treating autoimmune diseases, certain cancers, and in transplantation medicine, where excessive or misdirected B cell responses can be pathogenic. Targets and mechanisms include inhibitory co-receptors (CD22, FcγRIIb), cytokines (IL-10, BAFF antagonists), and regulatory T cells. Therapeutic agents include monoclonal antibodies against CD20/CD19/BlyS/BAFF receptors, and small molecule inhibitors affecting kinases downstream from the receptor complex.
- Other names
- B cell inhibitionB lymphocyte suppressionB cell proliferation blockade
02
Mechanism of action
Inhibition of B cell proliferation and/or survival
03
Biological functions
Immune response modulationB cell regulationCell proliferation inhibitionAutoantibody reduction
04
Disease associations
Autoimmune diseasesCancerTransplant rejectionInflammatory conditions
05
Safety considerations
ImmunodeficiencyIncreased risk of infectionInfusion reactionsProgressive multifocal leukoencephalopathy (PML)
06
Interacting drugs
Rituximab
3 more in the full profile.
07
Biomarkers
B cell countAutoantibody levelsCytokine levels
Beyond the preview
Go deeper on Immune system modulation via inhibition of B-cell proliferation (B-cell proliferation inhibition).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune system modulation via inhibition of B-cell proliferation (B-cell proliferation inhibition).